Titan Pharmaceuticals, Inc. announced the appointment of Federico Seghi Recli to its Board of Directors. In his most recent role as Chief Executive Officer, Mr. Seghi Recli led Molteni's successful transformation into a specialty pharmaceutical company focused on launching and commercializing innovative pharmaceutical products for the treatment of pain and addiction. Presntly, Molteni operates both directly and through its network of specialized partners in more than 30 countries and is a preferred and qualified partner of international organizations and non-governmental organizations such as UNICEF, UNDP and the IDA Foundation and Global Fund. Mr. Seghi Recli's career experience also includes senior roles with Merck S.p.A, including President and CEO from 2002 until 2005.